Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Other Non Operating Income (2010 - 2026)

Amarin Corp Plc\Uk (AMRN) posted quarterly Other Non Operating Income of $1.1 million for Q2 2026, up 1383.53% year-over-year from $73540.8 in Q2 2025, and up 480.32% quarter-over-quarter from $188000.0 in Q1 2026.

Amarin Corp Plcuk (AMRN) Other Non Operating Income (2010 - 2026) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Other Non Operating Income for 17 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Other Non Operating Income rose 1383.53% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $4.4 million (down 40.5% YoY), while the FY2025 annual figure was $3.3 million, down 63.17% from the prior year.
  • Other Non Operating Income grew to $1.1 million in Q2 2026 per AMRN's latest filing, from $188000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $11.1 million in Q4 2022 and bottomed at -$2.3 million in Q2 2022.
  • Historically, Other Non Operating Income has averaged $1.7 million across 5 years, with a median of $388000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 1080.63% — and 2026, when it surged 1383.53%.
  • Amarin Corp Plc\Uk's Other Non Operating Income stood at $11.1 million in 2022, then sank by 55.53% to $5.0 million in 2023, then soared by 40.24% to $6.9 million in 2024, then tumbled by 58.17% to $2.9 million in 2025, then plunged by 62.43% to $1.1 million in 2026.
  • Business Quant data shows AMRN's Other Non Operating Income at $1.1 million in Q2 2026, $188000.0 in Q1 2026, and $2.9 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.09 Mn
Mar 31, 2026 188,000.00
Dec 31, 2025 2.90 Mn
Sep 30, 2025 205,000.00
Jun 30, 2025 -85,000.00
Mar 31, 2025 253,000.00
Dec 31, 2024 6.94 Mn
Sep 30, 2024 265,000.00
Jun 30, 2024 145,000.00
Mar 31, 2024 1.55 Mn
Dec 31, 2023 4.95 Mn
Sep 30, 2023 -575,000.00
Jun 30, 2023 3.04 Mn
Mar 31, 2023 624,000.00
Dec 31, 2022 11.13 Mn
Sep 30, 2022 511,000.00
Jun 30, 2022 -2.26 Mn
Mar 31, 2022 -246,000.00
Dec 31, 2021 5.64 Mn
Sep 30, 2021 -57,000.00